Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review

被引：42
|
作者：
Uppendahl, Locke D. [1 ]
Dahl, Carly M. [2 ]
Miller, Jeffrey S. [3 ]
Felices, Martin [3 ]
Geller, Melissa A. [1 ]
机构：
[1] Univ Minnesota, Sch Med, Div Gynecol Oncol, Dept Obstet Gynecol & Womens Hlth, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Sch Med, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA
来源：
FRONTIERS IN IMMUNOLOGY | 2018年 / 8卷
关键词：
natural killer cells; immunotherapy; gynecologic malignancy; ovarian cancer; cervical cancer; TUMOR-INFILTRATING LYMPHOCYTES; APOPTOSIS-INDUCING LIGAND; OVARIAN-CANCER PATIENTS; CLASS-I MOLECULES; ANTI-CD20; MONOCLONAL-ANTIBODY; PERIPHERAL-BLOOD LYMPHOCYTES; IFN-GAMMA PRODUCTION; UTERINE NK CELLS; ACTIVATING RECEPTOR; ADOPTIVE TRANSFER;
D O I：
10.3389/fimmu.2017.01825
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Harnessing the immune system has proven an effective therapy in treating malignancies. Since the discovery of natural killer (NK) cells, strategies aimed to manipulate and augment their effector function against cancer have been the subject of intense research. Recent progress in the immunobiology of NK cells has led to the development of promising therapeutic approaches. In this review, we will focus on the recent advances in NK cell immunobiology and the clinical application of NK cell immunotherapy in ovarian, cervical, and uterine cancer.
引用
收藏
页数：15
相关论文
共 50 条
  • [41] Natural killer cell-based immunotherapy: From transplantation toward targeting cancer stem cells
    Dianat-Moghadam, Hassan
    Rokni, Mohsen
    Marofi, Faroogh
    Panahi, Yunes
    Yousefi, Mehdi
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (01) : 259 - 273
  • [42] Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy
    Joshi, Shweta
    Sharabi, Andrew
    PHARMACOLOGY & THERAPEUTICS, 2022, 235
  • [43] A cell-based screening assay for Natural Killer cell activity
    Blom, W. Marty
    van Nielen, Wim G. L.
    de Groene, Els. M.
    Albers, Ruud
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2009, 9 (06) : 746 - 752
  • [44] Optimization of Natural Killer T Cell-Mediated Immunotherapy in Cancer Using Cell-Based and Nanovector Vaccines
    Faveeuw, C.
    Trottein, F.
    CANCER RESEARCH, 2014, 74 (06) : 1632 - 1638
  • [45] Natural killer cell activation and dendritic cell-based vaccines
    Osada, T.
    Clay, T. M.
    Woo, C. Y.
    Morse, M. A.
    Lyerly, H. Kim
    MINERVA BIOTECNOLOGICA, 2007, 19 (03) : 91 - 104
  • [46] Combinatorial Natural Killer Cell-based Immunotherapy Approaches Selectively Target Chordoma Cancer Stem Cells
    Hoke, Austin T. K.
    Padget, Michelle R.
    Fabian, Kellsye P.
    Nandal, Anjali
    Gallia, Gary L.
    Bilusic, Marijo
    Soon-Shiong, Patrick
    Hodge, James W.
    London Jr, Nyall R.
    CANCER RESEARCH COMMUNICATIONS, 2021, 1 (03): : 127 - 139
  • [47] Driving natural killer cell-based cancer immunotherapy for cancer treatment: An arduous journey to promising ground
    Jiang, Dandan
    Zhang, Jingya
    Mao, Zhenkun
    Shi, Jinjin
    Ma, Peizhi
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 165
  • [48] Dendritic cell-based glioma immunotherapy (Review)
    Yamanaka, R
    Yajima, N
    Abe, T
    Tsuchiya, N
    Homma, J
    Narita, M
    Takahashi, M
    Tanaka, R
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 23 (01) : 5 - 15
  • [49] Infusion reactions in natural killer cell immunotherapy: a retrospective review
    Mamo, Tewodros
    Williams, Shelly M.
    Kinney, Stephanie
    Tessier, Katelyn M.
    DeFor, Todd E.
    Cooley, Sarah
    Miller, Jeffrey S.
    McKenna, David H.
    CYTOTHERAPY, 2021, 23 (07) : 627 - 634
  • [50] Role of natural killer cell function in dendritic cell-based vaccines
    Woo, Christopher Y.
    Clay, Timothy M.
    Lyerly, H. Kim
    Morse, Michael A.
    Osada, Takuya
    EXPERT REVIEW OF VACCINES, 2006, 5 (01) : 55 - 65
12345